Armistice Capital Master Fund Ltd., 10% Owner at ReShape Lifesciences Inc. (RSLS), bought 2,795 shares at $5.23 ($15K) on 2019-11-22, disclosed to the SEC on 2019-11-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.41 | 1,300 | $7K | 47.4% |
| 2 | $5.23 | 1,495 | $8K | 52.6% |
| Total | $5.31 avg | 2,795 | $15K | 100% |
| Filing → |
| AVTX | BUY | 2022-01-11 | $1.1M | — | Filing → |
| AYTU | BUY | 2020-12-15 | $8.0M | — | Filing → |
| CERC | BUY | 2020-12-07 | $49K | — | Filing → |